Correlation Between Tectonic Therapeutic, and Caribou Biosciences
Can any of the company-specific risk be diversified away by investing in both Tectonic Therapeutic, and Caribou Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tectonic Therapeutic, and Caribou Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tectonic Therapeutic, and Caribou Biosciences, you can compare the effects of market volatilities on Tectonic Therapeutic, and Caribou Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tectonic Therapeutic, with a short position of Caribou Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tectonic Therapeutic, and Caribou Biosciences.
Diversification Opportunities for Tectonic Therapeutic, and Caribou Biosciences
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Tectonic and Caribou is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Tectonic Therapeutic, and Caribou Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Caribou Biosciences and Tectonic Therapeutic, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tectonic Therapeutic, are associated (or correlated) with Caribou Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Caribou Biosciences has no effect on the direction of Tectonic Therapeutic, i.e., Tectonic Therapeutic, and Caribou Biosciences go up and down completely randomly.
Pair Corralation between Tectonic Therapeutic, and Caribou Biosciences
Given the investment horizon of 90 days Tectonic Therapeutic, is expected to generate 0.8 times more return on investment than Caribou Biosciences. However, Tectonic Therapeutic, is 1.26 times less risky than Caribou Biosciences. It trades about 0.08 of its potential returns per unit of risk. Caribou Biosciences is currently generating about -0.15 per unit of risk. If you would invest 4,804 in Tectonic Therapeutic, on September 26, 2024 and sell it today you would earn a total of 252.00 from holding Tectonic Therapeutic, or generate 5.25% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Tectonic Therapeutic, vs. Caribou Biosciences
Performance |
Timeline |
Tectonic Therapeutic, |
Caribou Biosciences |
Tectonic Therapeutic, and Caribou Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tectonic Therapeutic, and Caribou Biosciences
The main advantage of trading using opposite Tectonic Therapeutic, and Caribou Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tectonic Therapeutic, position performs unexpectedly, Caribou Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Caribou Biosciences will offset losses from the drop in Caribou Biosciences' long position.Tectonic Therapeutic, vs. Fate Therapeutics | Tectonic Therapeutic, vs. Caribou Biosciences | Tectonic Therapeutic, vs. Karyopharm Therapeutics | Tectonic Therapeutic, vs. X4 Pharmaceuticals |
Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |